期刊文献+

甲状腺过氧化物酶免疫染色在甲状腺细针抽吸细胞学检查中的诊断作用

Diagnostic value of thyroid peroxidase immunostaining in the fine needle aspirated thyroid tumor cells
下载PDF
导出
摘要 目的评价甲状腺过氧化物酶(TPO)在甲状腺细针抽吸细胞学检查中对良恶性甲状腺肿瘤的鉴别价值。方法采用免疫染色法观察TPO的单克隆抗体MoAb47在71例甲状腺肿瘤患者的甲状腺细针抽吸标本涂片中的表达,免疫染色结果的阳性判定根据两种不同方法进行:(1)De Mieeo法:80%以上甲状腺细胞染色为阳性,反之为阴性。(2)常规病理学法:5%或以上甲状腺细胞染色为阳性,低于5%甲状腺细胞染色为阴性。结果TPO在恶性甲状腺肿瘤细胞中的表达明显低于良性甲状腺肿瘤细胞。De Mieeo法和常规病理学法的敏感度和特异度分别为95.74%和91.67%、100.00%和58.33%;阳性及阴性预测值分别为95.74%和91.67%、82.46%和100.00%。结论TPO免疫染色用于甲状腺细针抽吸细胞学检查,可以提高甲状腺肿瘤的正确诊断率,而结果判定的方法不同可能影响TPO对甲状腺肿瘤的诊断价值。 Objective To evaluate immunostaining using the monoclonal antibody MoAM7 against thyroid peroxidase (TPO)in distinguishing between benign and malignant thyroid tumor ceils in fine needle aspiration cytology (FNAC) samples. Methods Fine needle aspirates (FNA) samples and frozen tissue sections were stained by immunocytochemistry using TPO MoAb47. Positive result of TPO immuno staining were judged by two methods : (1) De Micco method: samples were considered benign if more than 80% more of the thyroid cells of thyroid tumor were stained by TPO. Consequently, samples were considered malignant if 20% or more of the thyroid cells failed to stain for TPO. (2)Classical pathologic method:cases that showed specific staining of 5% or more of the tumor cells, regardless of staining intensity, were scored as positive for TPO. A negative result for TPO was considered consistent with cancer. Results Pattern with negative TPO staining in FNAC samples was found in 22 out of 24 which were diagnosed malignant tumor by histological pathology, while positive TPO staining pattern was found in 45 of 47 FNAC samples of benign tumor, with sensitivity and specificity at 95.74% and 91.67% respectively, judging by De Micco method. And negative TPO staining was found in 14 out of 24 which were diagnosed malignant tumor by histological pathology, with sensitivity and specificity at 100. 00% and 58.33% respectively, judging by classical pathologic method. Conclusion TPO has been proved to be a good marker serving for FNAC distinguishing between benign and malignant thyroid nodules. TPO immunostaining can be used in fine needle aspirates as a reliable tool to improve FNAC diagnosis, but the application would be limited by the judgment method.
出处 《中国医师进修杂志(内科版)》 2007年第4期17-20,共4页 Chinese Journal of Postgraduates of Medicine
关键词 甲状腺肿瘤 甲状腺过氧化物酶 细针 Throid neoplasm Thyroid peroxidase Fine needle
  • 相关文献

参考文献10

  • 1De Micco C, Zoro P, Garcia S, et al. Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine - needle aspiration biopsy. Eur J Endoerinol, 1994,131 (5) :474 - 479.
  • 2Weber KB, Shroyer KR, Heinz DE ,et al. The use of a combination of galectin -3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol, 2004,122 (4) :524 -531.
  • 3Di Cristofaro JD, Silvy M, Lanteaume A, et al. Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf, ras and pax 8 genes. Endocr Relat Cancer,2006,13(2) :485 -495.
  • 4Le Fourn V, Ferrand M,Franc JL. Differential expression of thyroperoxidase mRNA splice variants in human thyroid tumors. Biochim Biophys Acta, 2004,1689(2) : 134 - 141.
  • 5Christensen L, Blichert- Toft M, Brandt M, et al. Thyroperoxidase(TPO) immunostaining of the solitary cold thyroid nodule. Clin Endocrinol (Oxf), 2000, 53(2) :161 -169.
  • 6Faroux MJ, Theobald S, Pluot M, et al. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine - needle aspiration. Pathol Res Pract,1997,193(10) :705 -712.
  • 7De Micco C, Vassko V, Henry JF. The value of thyroid peroxidase immunohistechemistry for preoperative fine - needle aspiration diagnosis of the follicular variant of papillary thyroid cancer. Surgery, 1999,126(6) :1200 - 1204.
  • 8蒋玲,董建军,张晓黎,袁鹰,张廷国,管庆波,朱光耀.良性及恶性甲状腺肿瘤端粒酶活性的表达[J].中华内分泌代谢杂志,2002,18(2):136-137. 被引量:5
  • 9Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine - needle aspiration biopsy for the diagnosis of thyroid turnouts. Clin Endocrinol ( Oxf), 2002, 56 ( 3 ) :281 - 290.
  • 10张延美,蒋玲,曲卫,袁鹰,许复郁,王少莲.半乳糖凝集素3表达在良恶性甲状腺肿瘤鉴别中的意义[J].中华内分泌代谢杂志,2005,21(2):121-125. 被引量:13

二级参考文献21

  • 1白耀.甲状腺恶性肿瘤诊断和治疗的热点讨论[J].中华内分泌代谢杂志,2004,20(4):283-286. 被引量:19
  • 2Orlandi F, Saggiorato E, Pivano G, et al, Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res, 1998,58:3015-3020.
  • 3Barondes SH, Cooper DN, Gitt MA, et al. Galectins, Structure and function of a large family of animal lectins. J Biol Chem, 1994,269:20807-20810.
  • 4Yoshii T, Inohara H, Takenaka Y, at el. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol, 2001,18:787-792.
  • 5Perillo NL, Marcus ME, Baum LG. Galectins: versatik modulators of cell adhesion, cell proliferation, and cell death. J Mol Med, 1998,76:402-412.
  • 6Nangia-Makker P, Honjo Y, Sarvis R, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol, 2000,156:899-909.
  • 7Akahani S, Nangia-Makker P, Inohara H, et al. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res, 1997,57:5272-5276.
  • 8Xu XC, NI Naggar AK, Lotan R, et al. Differential expression of galectin-1 and galectin-3 in thyoid tumors: Potential diagnostic implications. Am J Pathol, 1995,147:815-822.
  • 9Inohara H, Honjo Y, Yoshii T, et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer, 1999,85:2475-2484.
  • 10Coli A, Bigotti G, Zucchetti F, et al. Galectin-3, a marker of well-differentiated thyroid cancirnoma, is expressed in thyroid nodules with cytological atypia. Histopathology, 2002,40:80-87.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部